within Pharmacolibrary.Drugs.C_CardiovascularSystem.C01B_AntiarrhythmicsClassIAndIii.C01BA08_Prajmaline;

model Prajmaline_1
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_2C_enteral(
    weight = 70,
    F = 0.85,
    Cl = 2.9166666666666666e-06,
    adminDuration = 600,
    adminMass = 100 / 1000000,
    adminCount = 1,
    Vd = 0.0022,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.0013333333333333333,
    Tlag = 600,
    Vdp = 0.0025,
    k12 = 4.183333333333334e-06,
    k21 = 4.183333333333334e-06);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Prajmaline_1</td></tr><tr><td>ATC code:</td><td>C01BA08_1</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>2</td></tr>
    <tr><td>dosage:</td><td>100</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>2.2</td><td>L</td></tr>
    <tr><td>clearance:</td><td>175</td><td>ml/min</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Prajmaline is an antiarrhythmic drug of the class Ia, developed from the plant alkaloid ajmaline. It is used to treat certain cardiac arrhythmias, such as ventricular and supraventricular tachycardias. Prajmaline is not widely approved or used in clinical practice today, with usage mainly reported in some European countries and limited global distribution.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adults (male and female) following oral administration.</p><h4>References</h4><ol><li><p>Breuel, HP, et al., &amp; Bondy, S (1991). Pharmacokinetics and relative bioavailability of prajmalium bitartrate after single oral dosing. <i>Arzneimittel-Forschung</i> 41(12) 1222–1225. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/1815520/\">https://pubmed.ncbi.nlm.nih.gov/1815520</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.C.C01BA08_1 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Prajmaline_1;
